Fierce Biotech

Novartis joins Lilly, AZ in China expansion with $480M commitment to boost manufacturing, R&D

Published

2 weeks ago

on

Novartis is investing more than 3.3 billion Chinese yuan (roughly $480 million) to soup up its manufacturing facility in Beijing and strengthen its R&D campus in Shanghai, where the company’s China headquarters are also located.

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version